- Home
- ABVC vs DTIL Comparison
ABVC vs DTIL Comparison
Compare ABVC & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- DTIL
- Stock Information
- Founded
- ABVC 2015
- DTIL 2006
- Country
- ABVC United States
- DTIL United States
- Employees
- ABVC N/A
- DTIL N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- ABVC Health Care
- DTIL Health Care
- Exchange
- ABVC Nasdaq
- DTIL Nasdaq
- Market Cap
- ABVC 52.1M
- DTIL 55.3M
- IPO Year
- ABVC N/A
- DTIL 2019
- Fundamental
- Price
- ABVC $2.77
- DTIL $8.43
- Analyst Decision
- ABVC
- DTIL Strong Buy
- Analyst Count
- ABVC 0
- DTIL 2
- Target Price
- ABVC N/A
- DTIL $47.00
- AVG Volume (30 Days)
- ABVC 84.1K
- DTIL 163.0K
- Earning Date
- ABVC 11-13-2025
- DTIL 11-07-2025
- Dividend Yield
- ABVC N/A
- DTIL N/A
- EPS Growth
- ABVC N/A
- DTIL N/A
- EPS
- ABVC N/A
- DTIL N/A
- Revenue
- ABVC $391,242.00
- DTIL $1,261,000.00
- Revenue This Year
- ABVC $735.18
- DTIL N/A
- Revenue Next Year
- ABVC N/A
- DTIL $135.19
- P/E Ratio
- ABVC N/A
- DTIL N/A
- Revenue Growth
- ABVC 186.84
- DTIL N/A
- 52 Week Low
- ABVC $0.40
- DTIL $3.61
- 52 Week High
- ABVC $5.48
- DTIL $9.14
- Technical
- Relative Strength Index (RSI)
- ABVC 47.60
- DTIL 77.66
- Support Level
- ABVC $2.86
- DTIL $6.63
- Resistance Level
- ABVC $3.05
- DTIL $8.49
- Average True Range (ATR)
- ABVC 0.15
- DTIL 0.55
- MACD
- ABVC -0.02
- DTIL 0.15
- Stochastic Oscillator
- ABVC 26.59
- DTIL 89.61
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.